Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:

‍

Merck announced it will expand a relationship with Greenphire, utilizing Greenphire's ClinCard rideshare program to help reduce the financial and travel burdens on clinical trial participants. (Fierce Biotech)

Using learning developed during the COVID-19 pandemic, and the aid of a heart-lung bypass machine, a team led by Dr. Ankit Bharat at Northwestern Medicine in Chicago succeeded in performing a novel treatment for stage 4 lung cancer—a double lung transplant. (NBC News)
‍
Stressing the need for participation and funding, Cathy Eng, MD, the David H. Johnson Professor of Surgical and Medical Oncology at Vanderbilt University Medical Center, speaks with Tom Wilemon about her recent panel at the White House Cancer Moonshot Colorectal Cancer Forum. (VUMC Reporter)

‍
‍

Our Culture

“I’ve been at the company over seven years, and it’s been really cool to watch the company grow and continue to increase how we help our clients. One of the many things I like about my job is that it’s not always the same thing every day, because each client is unique. It makes every day interesting.

Judi is a platform. It’s an adjudication tool, but it’s also more. It’s a whole collaborative workflow process tool. It works with DSMB, Eligibility, anything.”

   –Stephen, Lead Engineer

‍

‍‍
‍

About Judi

Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.

‍